BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 15826288)

  • 1. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
    Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
    Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of invasive aspergillosis among allogeneic hematopoietic stem cell transplant patients receiving voriconazole prophylaxis.
    Siwek GT; Pfaller MA; Polgreen PM; Cobb S; Hoth P; Magalheas-Silverman M; Diekema DJ
    Diagn Microbiol Infect Dis; 2006 Jul; 55(3):209-12. PubMed ID: 16626917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of prophylactic voriconazole for three months after lung transplantation does not reduce infection with Aspergillus: a retrospective study of 147 patients.
    Tofte N; Jensen C; Tvede M; Andersen CB; Carlsen J; Iversen M
    Scand J Infect Dis; 2012 Nov; 44(11):835-41. PubMed ID: 22803836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
    Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
    Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Voriconazole prophylaxis in lung transplant recipients.
    Husain S; Paterson DL; Studer S; Pilewski J; Crespo M; Zaldonis D; Shutt K; Pakstis DL; Zeevi A; Johnson B; Kwak EJ; McCurry KR
    Am J Transplant; 2006 Dec; 6(12):3008-16. PubMed ID: 17062003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
    He SY; Makhzoumi ZH; Singer JP; Chin-Hong PV; Arron ST
    Transpl Infect Dis; 2015 Feb; 17(1):14-20. PubMed ID: 25620387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive aspergillosis in a tertiary-care hospital in Thailand.
    Kiertiburanakul S; Thibbadee C; Santanirand P
    J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli.
    Lionakis MS; Lewis RE; Torres HA; Albert ND; Raad II; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2005 May; 52(1):15-20. PubMed ID: 15878437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis.
    Denning DW; Ribaud P; Milpied N; Caillot D; Herbrecht R; Thiel E; Haas A; Ruhnke M; Lode H
    Clin Infect Dis; 2002 Mar; 34(5):563-71. PubMed ID: 11807679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients.
    Oshima K; Kanda Y; Asano-Mori Y; Nishimoto N; Arai S; Nagai S; Sato H; Watanabe T; Hosoya N; Izutsu K; Asai T; Hangaishi A; Motokura T; Chiba S; Kurokawa M
    J Antimicrob Chemother; 2007 Aug; 60(2):350-5. PubMed ID: 17584800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis.
    Luong ML; Chaparro C; Stephenson A; Rotstein C; Singer LG; Waters V; Azad S; Keshavjee S; Tullis E; Husain S
    Transplantation; 2014 Feb; 97(3):351-7. PubMed ID: 24305637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
    Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
    Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preemptive treatment with voriconazole in lung transplant recipients.
    Neoh CF; Snell GI; Levvey B; Kotsimbos T; Morrissey CO; Slavin MA; Stewart K; Kong DC
    Transpl Infect Dis; 2013 Aug; 15(4):344-53. PubMed ID: 23527908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience with voriconazole in invasive aspergillosis].
    Thiel E; Schwartz S
    Mycoses; 2003; 46 Suppl 2():3-7. PubMed ID: 15055137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
    Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
    Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspergillosis in pulmonary transplantation].
    de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
    Martin T; Sharma M; Damon L; Kaplan L; Guglielmo BJ; Working M; O'Malley R; Hwang J; Linker C
    Transpl Infect Dis; 2010 Feb; 12(1):45-50. PubMed ID: 19793068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.